Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
- Posted on February 11, 2026
- By CNBC
- 2 Views
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.
